It's On Us!

Try Value Investor Insight for one month — absolutely free — and see for yourself how valuable a subscription can be. You’ll receive two issues as well as our regular Bonus Content e-mails. It's totally risk-free: There is no obligation and no payment required.

“I read and enjoy Value Investor Insight.”

— Warren Buffett, Berkshire Hathaway

Start profiting from these exclusive benefits!

Value Investor Insight is published online and in PDF format monthly for paid subscribers at www.valueinvestorinsight.com. Trial subscribers will have access to two trial issues online and will receive VII Bonus Content via e-mail during their trial period.

  • Great ideas, the scarce and valuable currency of successful investing. One great investment idea will return many times over the price of a subscription. The best news is that Value Investor Insight strives to deliver many such great ideas each month.
  • Strategies of the best professional money managers. Value Investor Insight features in-depth interviews and ideas only from the world’s most accomplished investors – some famous, others decidedly low-profile.
  • Uncovering value the markets are missing. Herd behavior, imperfect information and plain-old investor irrationality create inefficiencies across markets, among asset classes, and over time. Value Investor Insight helps identify these inefficiencies and tells you how to profit from them.
  • Cutting through ever-increasing market and media “noise.” The barrage of so-called investing information often leaves investors more confused than enlightened. Value Investor Insight cuts through the “noise,” presenting fully-analyzed investment ideas clearly and concisely.
  • Bonus Content delivered by e-mail. In addition to your monthly issues of VII, you will also receive timely news commentary, meeting transcripts, investor letters, special reports, reviews and other information meant to help inform your investment decisions.
  • Access to all back issues. Paid subscribers gain access to a complete issue archive with all investment and company insight from previous issues, not just those they've paid for.
What's in the Latest Issue?

Finding mispriced value at both ends in a still bifurcated market, including in AbbVie, Ashland, Kirby, UPS and Clorox.


Read More

Looking beyond the numbers to find upside in less-followed ideas such as Genmark, Omnicell, Brooks Automation and Veeco.


Read More

How a legendary investor is passing on his life's experience – as well as the reins of his namesake firm – to the next generation.


Read More

An option to consider if investors' lack of concern about inflation turns out to be wrong.


Read More

A down-to-earth opportunity if the long-term prospects for global air travel remain intact.


Read More
Investment Highlights
AbbVie, Aéroports de Paris, Ashland, Brooks Automation, DS Smith, GenMark Diagnostics, Intercontinental Exchange, Kirby, Omnicell, Veeco Instruments, Washington Trust
Other Companies in this Issue:
Best Buy, Cabot Oil & Gas, Caleres, Clorox, Designer Brands, Hub Group, United Parcel Service, Zoom